SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-094738
Filing Date
2024-08-09
Accepted
2024-08-09 16:05:13
Documents
16
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A atha-20240630.htm   iXBRL 10-Q/A 134142
2 EX-10.1 atha-ex10_1.htm EX-10.1 32338
3 EX-10.2 atha-ex10_2.htm EX-10.2 109448
4 EX-31.3 atha-ex31_3.htm EX-31.3 7411
5 EX-31.4 atha-ex31_4.htm EX-31.4 7561
6 GRAPHIC img60298552_0.jpg GRAPHIC 17633
  Complete submission text file 0000950170-24-094738.txt   1722788

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20240630.xsd EX-101.SCH 878212
18 EXTRACTED XBRL INSTANCE DOCUMENT atha-20240630_htm.xml XML 8458
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39503 | Film No.: 241192532
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)